BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND KLF6, RP11-184A2_1, 1316, ENSG00000067082, ST12, DKFZp686N0199, CPBP, Zf9, COPEB, ZF9, PAC1, GBF, BCD1 AND Treatment
14133 results:

  • 1. Trends in Early-Stage Cervical cancer Management in the US: A National cancer Database Analysis.
    Wolf J; Wu Y; Hayek J; Zhang Q; Alagkiozidis I
    Curr Oncol; 2024 May; 31(5):2836-2845. PubMed ID: 38785496
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Insights into pelvic insufficiency fracture following pelvic radiotherapy for cervical cancer: a comparative review.
    Haque M; Hossen MS
    BMC Womens Health; 2024 May; 24(1):306. PubMed ID: 38783273
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
    Upadhyay AK; Kumar M; Prakash A; Kumar A
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
    PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
    Liu Y; Song X; Zhang H; Feng F; Zhao J; Yang J; Ren T; Wan X; Jiang F; Li Y; Xiang Y
    Orphanet J Rare Dis; 2024 May; 19(1):214. PubMed ID: 38778412
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.
    Erturk A; Korkmaz E; Arslantas Z; Bekdemir S; Erturk NK
    Rev Assoc Med Bras (1992); 2024; 70(5):e20231115. PubMed ID: 38775501
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
    Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
    J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
    Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
    BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
    Dong B; Zhou SF
    BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer.
    Lu X; Zhang W; Zhang J; Ren D; Zhao P; Ying Y
    J Cell Mol Med; 2024 May; 28(9):e18361. PubMed ID: 38722283
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6
    De Wispelaere W; Annibali D; Tuyaerts S; Messiaen J; Antoranz A; Shankar G; Dubroja N; Herreros-Pomares A; Baiden-Amissah REM; Orban MP; Delfini M; Berardi E; Van Brussel T; Schepers R; Philips G; Boeckx B; Baietti MF; Congedo L; HoWangYin KY; Bayon E; Van Rompuy AS; Leucci E; Tabruyn SP; Bosisio F; Mazzone M; Lambrechts D; Amant F
    Clin Transl Med; 2024 May; 14(5):e1655. PubMed ID: 38711203
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    Zeng F; Guo P; Xia M; He M
    J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
    J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
    Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
    Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
    PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Metformin for endometrial hyperplasia.
    Shiwani H; Clement NS; Daniels JP; Atiomo W
    Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y; Wang W; Tang J; Hu K; Zhang F
    BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
    Chen W; Xie X; Liu C; Liao J; Wei Y; Wu R; Hong J
    Cell Signal; 2024 Jul; 119():111192. PubMed ID: 38685522
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
    Huang Y; Zhou S; Su Y; Pang Z; Cai S
    Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 707.